Valtoco 10 MG nasal sprays
Ended Awarded
- Contract number
- SPE2DB26FQTD4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,107
Award facts
- Contract value 100% obligated
- $23,106.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $23,106.52 to AmerisourceBergen Drug Corp for the supply of Valtoco 10 mg nasal sprays. The contract, awarded on November 4, 2025, with completion scheduled for November 5, 2025, utilizes firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive global pharmaceutical support vehicle running through December 2026 that enables the contractor to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide.
The award represents a routine pharmaceutical procurement within the Defense Logistics Agency's medical supply chain operations, supporting federal healthcare needs for military personnel and related government healthcare systems. Valtoco (diazepam) nasal spray is a specialty medication used for acute seizure management, reflecting the broad therapeutic portfolio that AmerisourceBergen maintains under its prime vendor agreement with DLA. The competitively awarded, non-set-aside status of this delivery order demonstrates the contractor's established capability to meet federal procurement requirements and its critical role in ensuring consistent access to essential pharmaceutical products across the Department of Defense medical infrastructure.
Quick answers
Who was awarded contract SPE2DB26FQTD4?
SPE2DB26FQTD4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 4, 2025.
How much is contract SPE2DB26FQTD4 worth?
The government has obligated $23,107 on SPE2DB26FQTD4.
Is contract SPE2DB26FQTD4 an order under another contract?
Yes. SPE2DB26FQTD4 is a delivery order under SPE2DB20D3101, an indefinite delivery contract.
Was contract SPE2DB26FQTD4 competed?
The extent of competition for SPE2DB26FQTD4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award